Yunnan Hospital Fined 2,000 Yuan for Expired Medications

A psychiatric hospital in Zhaotong, Yunnan Province has been fined just 2,000 yuan (approximately US$275) after regulators discovered it was using multiple types of expired medications on patients, sparking widespread public outrage and raising serious questions about the effectiveness of healthcare regulatory enforcement in China.

The penalty was issued on May 27 by the Ludian County Market Supervision Bureau against Zhaotong Ciming Psychiatric Hospital Co., Ltd., according to information disclosed on Credit China, the national credit information platform, and reported by Pengpai News (The Paper).

The Violation

Regulators confiscated four types of expired medications from the hospital: 86 tablets of raceanisodamine, 68 tablets of lithium carbonate, 80 tablets of dexamethasone, and 4 tablets of roxithromycin. These drugs are used to treat conditions including psychiatric disorders, inflammation, and bacterial infections — making their use on vulnerable psychiatric patients particularly concerning.

The hospital, established in 2020 as a private healthcare enterprise located in Taoyuan Hui Township, Ludian County, was ordered to forfeit the expired drugs in addition to paying the fine.

A Pattern of Non-Compliance

This is not the first regulatory violation for Zhaotong Ciming Psychiatric Hospital. In June 2025, the Zhaotong Ecological Environment Bureau fined the hospital a total of 229,000 yuan for two environmental violations: constructing a 4,079-square-meter capacity improvement project without submitting an environmental impact assessment report, and operating from March 2024 without completing environmental protection facility acceptance procedures.

This history of repeated violations raises concerns about the hospital’s overall management standards and its commitment to regulatory compliance.

Stark Disparities in Penalties

The 2,000 yuan fine in this case is dramatically lower than comparable penalties imposed on other Chinese hospitals for similar offenses, even when the expired drugs had not actually been administered to patients.

In a 2024 case, Chengdu Xindu Yining Hospital — also a psychiatric facility — was fined 55,000 yuan (27.5 times more) after regulators found expired haloperidol tablets and naloxone injections on a pharmacy shelf. Critically, the Chengdu hospital received a “reduced penalty” because the drugs had NOT been used or sold, and were sourced legally, as Pengpai News reported.

In another case from 2020, a county hospital in Shandong was fined 100,000 yuan (50 times more) for storing 81 vials of expired ephedrine injection in a controlled drugs safe. The hospital challenged the penalty in court but lost, according to a case published by the Shandong High Court.

Legal Framework and Questions

Under China’s Drug Administration Law, expired drugs are classified as “inferior drugs” (劣药), and medical institutions that use them face fines of 10 to 20 times the value of the drugs involved. The minimal 2,000 yuan penalty in this case suggests either that the expired medications had very low market value, that the regulatory authority applied a reduced penalty under mitigating circumstances, or that the fine was calculated under a different legal provision.

The fact that the drugs in the Yunnan case were actually being used on patients — rather than merely stored — makes the comparatively light penalty particularly difficult to justify.

Public Reaction and Implications

The story has been widely republished by major Chinese media outlets including Sohu and Sina Finance, reflecting significant public interest. Online commentators have expressed disbelief at the minimal fine, with many questioning whether such a penalty can serve as any meaningful deterrent.

For psychiatric patients — a particularly vulnerable population who may struggle to advocate for themselves — the use of expired medications poses serious risks, including reduced efficacy or potential toxicity. The case highlights broader concerns about regulatory consistency across China’s healthcare system and whether current enforcement mechanisms adequately protect patient safety.

What to Watch

The case has drawn attention to the discretion exercised by county-level market supervision bureaus in applying penalties. Given the public outcry and media scrutiny, higher-level authorities may review the case or issue guidance to ensure more consistent enforcement in the future. Questions also remain about whether patients at the hospital suffered any adverse effects from the expired medications and what corrective actions the hospital has taken.